With shares of Wal-Mart (NYSE:WMT) trading around $77, is WMT an OUTPERFORM, WAIT AND SEE or STAY AWAY? Let�� analyze the stock with the relevant sections of our CHEAT SHEET investing framework:
T = Trends for a Stock’s MovementWal-Mart operates retail stores in various formats around the world. The company aims to price items at the lowest price every day. Wal-Mart operates in three business segments: the Walmart U.S. segment, the Walmart International segment, and the Sam�� Club segment. It operates retail stores, restaurants, discount stores, supermarkets, supercenters, hypermarkets, warehouse clubs, apparel stores, Sam��� Clubs, neighborhood markets, and other small formats, as well as Walmart.com and Samsclub.com. Through its retail channels, Wal-Mart is able to provide a variety of products and services at very affordable prices to consumers and companies worldwide.
Wal-Mart is an especially hot place for summer lovers to take advantage of, as it provides a one-stop shop for anything a beach bum�� heart desires.�Customers know that they can get in and out of Wal-Mart quickly and find all of their summer gear at relatively low prices.�One out of three customers give Wal-Mart�� summer products a perfect 10, and 33.8 percent assert that they would be extremely likely to recommend the store. Wal-Mart is undoubtedly looking at a very successful summer sales quarter.�For consumers and businesses looking for one location that contains a wide variety of products and services, Wal-Mart is the spot and will continue to be well into the future.
Hot Low Price Stocks To Buy For 2014: Accelr8 Technology Corporation(AXK)
Accelr8 Technology Corporation focuses on the research and development, and commercialization of proprietary surface chemistry formulation and quantitative bio-analytical measurement instruments. The company is developing BACcel system, a rapid diagnostic platform for diagnosis in life-threatening bacterial infections. It also develops and licenses OptiChem surface coatings for use in microarraying components. The company was founded in 1982 and is based in Denver, Colorado.
Hot Low Price Stocks To Buy For 2014: ACADIA Pharmaceuticals Inc.(ACAD)
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on drug discovery and clinical development of novel treatments for central nervous system disorders. The company has a portfolio of four product candidates, including pimavanserin, which is in Phase III clinical development as a treatment for Parkinson's disease psychosis. It is also developing AGN-XX/YY, a product candidate in Phase II for chronic pain; and AC-262271, a product candidate in Phase I for glaucoma in collaboration with Allergan, as well as AM-831, a product candidate in IND-track development in collaboration with Meiji Seika Kaisha, Ltd. In addition, ACADIA Pharmaceuticals Inc. is developing two preclinical programs in the area of Parkinson?s disease. The product candidates in the company?s pipeline emanate from discoveries made using its proprietary drug discovery platform. The company was founded in 1993 and is headquartered in San Diego, California.
Advisors' Opinion:- [By Selena Maranjian]
D. E. Shaw reduced its stake in lots of companies, including Acadia Pharmaceuticals (NASDAQ: ACAD ) and Exelixis (NASDAQ: EXEL ) . Acadia has skyrocketed over the past year, rising more than 10-fold, on high hopes for its pimavanserin drug, which treats psychosis in patients with Parkinson's disease. If the drug gains FDA approval, it will enjoy little competition and could be a big winner for Acadia. The company thinks the drug might be effective against psychosis related to Alzheimer's disease as well and is conducting trials for that, too. Acadia is also raising about $100 million via a secondary stock offering to fund ongoing and future trials.
- [By Bio-Wire]
Baker Bros. Advisors is a ~5 BB small & micro-cap focused biotechnology fund run by Julian Baker and Felix Baker. The fund has generated exceptional returns this year ��largely due to a huge long position they started in ACADIA Pharmaceuticals (NASDAQ: ACAD) (YTD = +481%). While the fund is quite secretive, it is required file SEC Form 13F which allows the public to see which particular biotech stocks are being accumulated.
- [By Brian Orelli]
There goes the short-term bear thesis on ACADIA Pharmaceuticals (NASDAQ: ACAD ) .
I had recommended staying away from the company for now because it looked too risky with a long wait before the company could complete its second phase 3 trial for pimavanserin in patients with Parkinson's disease psychosis.
Top Dividend Stocks To Invest In 2014: Versant Corporation(VSNT)
Versant Corporation engages in the design, development, marketing, and support of object-oriented database management system products to solve complex data management and data integration problems of enterprises. Its flagship product includes the Versant Object Database, an object database management system designed to support multi-user commercial applications in distributed computing environments that enables users to store, manage, and distribute information that cannot be administered through traditional database technologies. The company also provides FastObjects, an object database management system for use as an embedded data management system to be integrated in various products, including medical devices, vending machines, telecom equipment, and defense systems; and db4o, an open source object database that enables Java and .NET developers to store and retrieve application objects with one line of code targeting the embedded device market. In addition, it offers m aintenance and technical support services; and training and consulting services to assist customers in the design, development, training, and management of applications that are built based on its core products. The company?s software is used in strategic distributed applications, such as network modeling and management, fault diagnosis, fraud prevention, and service activation and assurance, as well as in customer billing, scheduling, and other applications. It markets its products principally through its direct sales force, as well as through value-added resellers, systems integrators, and distributors to companies in telecommunications, government and defense, media, technology, financial services, transportation, and healthcare industries in North America, Europe, and Asia. The company was formerly known as Versant Object Technology Company and changed its name to Versant Corporation in July 1998. Versant Corporation was founded in 1988 and is headquartered in Redwood C ity, California.
Hot Low Price Stocks To Buy For 2014: Diploma(DPLM.L)
Diploma PLC supplies specialized technical products and services in Europe, North America, and internationally. The company?s Life Sciences segment supplies consumables, instrumentation, and related services to the healthcare and environmental industries. This segment offers consumables and instruments used in the diagnostic testing of blood, tissue, and other samples in hospital pathology laboratories; specialty electrosurgery and endoscopy equipment, and consumables for use in the operating rooms and endoscopy suites; analyzers for detecting and measuring specific elements in liquids, solids, and gases, as well as containment enclosures for potent powder handling; and equipment and services for the monitoring and control of environmental emissions. The company?s Seals segment supplies hydraulic seals, gaskets, cylinders, components, and kits for heavy mobile machinery and industrial equipment. This segment provides a next day delivery service for seals, seal kits, and cylinders used in heavy mobile machinery applications; gasket and seal kits for heavy duty diesel engines, transmissions, and hydraulic cylinders used in off road and marine applications; hydraulic kits to install attachments on excavators; O-rings, moulded and machined parts, PTFE products, and shaft seals; and precision seals for hearing aids and heavy duty seals for wind power mills. The company?s Controls segment supplies specialized wiring, connectors, fasteners, and control devices for technically demanding applications. This segment offers wiring, interconnect, electro-mechanical, and fastener products for use in a range of technically demanding applications in various industries, including defense and aerospace, motorsport, energy, medical, and general industrial; flexible braided products and multi-core cables; and control devices used in the sensing, measurement, and control of temperature and pressure. Diploma PLC was incorporated in 1931 and is based in London, the United Kingdom.
Hot Low Price Stocks To Buy For 2014: Paradigm Medical Industries Inc (PDMI)
Paradigm Medical Industries, Inc., incorporated in October 1989, develops, manufactures, markets and sells ophthalmic diagnostic instrumentation and related accessories, including disposable products. The diagnostic products that the Company manufacturers, markets and sells consist of the P60 UBM Ultrasound Biomicroscope, two perimeters - the LD 400 and the TKS 5000, and the Blood Flow Analyzer. The diagnostic products that the Company markets and sells, which are manufactured by its Italian partner, Costruzione Strumenti Oftalmici srl (CSO), are the Paramax, corneal topographers - the Paravue 300 and the Surveyor 500, and the Paracam 1000. The P60 UBM Ultrasound biomicroscope is the third-generation of UBM devices. The CSO product to be distributed and sold by the Company is the Paramax. Other CSO products to be sold by the Company are the Paravue 300, a corneal topographer with the ability to display live images on a computer monitor; the Surveyor 500, a corneal topographer with a rotating Scheimpflug camera with placido disk, and the Paracam 1000, a specular microscope for endothelial cell evaluations.
Diagnostic Eye Care Products
The Company�� diagnostic eye care products include blood flow analyzer, dicon perimeters, P60 UBM ultrasound biomicroscopes, and Paramax and other products manufactured by Costruzione Strumenti Oftalmici srl. The blood flow analyzer device measures not only intraocular pressure but also pulsatile ocular blood flow, the reduction of which may cause nerve fiber bundle death through oxygen deprivation thus resulting in visual field loss associated with glaucoma. The Company's blood flow analyzer is a portable automated in-office system that presents a method for ocular blood flow testing for the ophthalmic and optometric practitioner. The device is a portable desktop system that utilizes an Air Membrane Applanation Probe (AMAP), which can be attached to any model of standard examination slit lamp, which is then placed on the cornea of the patient! 's eye to measure the intraocular pressure within the eye.
Dicon perimeters consist of the LD 400 and the TKS 5000, and software consisting of Field Lin FieldView and Advanced Field View. Perimeters are used to determine retinal sensitivity testing the visual pathway. Perimetry is reimbursable worldwide. The Dicon perimeters feature kinetic fixation and voice synthesis in 27 different languages. The LD 400FT, or Fast Threshold Autoperimeter, is the successor to the LD 400. The device is an autoperimeter used to measure patient visual fields. The LD 400FT is identical in hardware to the LD 400 but it uses new software to enable a threshold test. The P60 biomicroscope represents the third-generation of UBM devices. The Paramax is to be sold in North America on an exclusive basis. The Paramax performs tests for the early screening and follow up of pathologies, such as glaucoma, age related macular degeneration, vascular retinal degeneration, and other optic nerve diseases.
Surgical Products
The Company�� surgical products include Precisionist Thirty Thousand, Ocular Surgery Workstation and Photon Laser System. The Precisionist Thirty Thousand is the Company's core phaco surgical technology. As of December 31, 2009, the Precisionist is not manufactured by the Company. The system features a graphic color display and on board computer and graphic user interface linked to a soft key membrane panel for flexible programmable operation. The system provides real-time on-the-fly adjustment capabilities for each surgical parameter during the surgical procedure for high-volume applications. In addition, the Precisionist provides one hundred pre-programmable surgery setups, with a second level of subprogrammed custom modes within each major surgical screen (ultrasound phaco and
irrigation/aspiration modes).
The Ocular Surgery Workstation comprises the base system of the Precisionist
Thirty Thousand and is the first system, to the Company's knowledge,! which us! es the expansive capabilities of today's advanced computer technology to offer seamless open architecture expandability of the system hardware and software modules. The Workstation utilizes an embedded open architecture computer developed for the Company and controlled by a software system developed by the Company that interfaces with all components of the system. Ultrasound, fluidics (irrigation), aspiration, venting, coagulation and anterior vitrectomy (pneumatic) are all included in the base model.
The Photon laser cataract system is designed to be installed as a seamless plug-in upgrade or add-on to the Company's Precisionist' Ocular Surgery Workstation. The Photon laser utilizes the on board microprocessor computer of the Workstation to generate short pulse laser energy developed through the patented LCP to targeted cataract tissue inside the eye, while simultaneously irrigating the eye and aspirating the diseased cataract tissue from the eye. In addition to the cataract surgery equipment, the Company's surgical systems are designed to utilize accessory instruments and disposables. These include replacement ultrasound tips, sleeves, tubing sets and fluidics packs, instrument drapes and laser cataract probes. The Company focuses on expanding its disposable accessories as it penetrates the cataract surgery market and expands the treatment applications for its Workstation.
The Company competes with Sonomed, Tomey, Nidek, OTI and Quantel.
Hot Low Price Stocks To Buy For 2014: Central European Distribution Corp (CEDCQ.PK)
Central European Distribution Corporation (CEDC), incorporated on September 4, 1997, operates primarily in the alcohol beverage industry. CEDC is a producer of vodka and is Central and Eastern Europe�� integrated spirit beverages business. During the year ended December 31, 2011, as measured by total volume, the Company produced and distributed approximately 33.2 million nine-liter cases . The Company�� business primarily involves the production and sale of its own spirit brands (principally vodka), and the importation on a basis of a range of spirits, wines and beers. Its primary operations are conducted in Poland and Russia. In addition the Company also has operations in Hungary and Ukraine. CEDC has six manufacturing facilities located in Poland and Russia. On February 7, 2011, the Company completed purchasing of the remaining stake of the Whitehall Group.
CEDC is an importer of spirits, wines and beers in Poland, Russia and Hungary. The Company mai ntains import contracts for a number of internationally recognized brands, including Jim Beam Bourbon, Campari, Jagermeister, Remy Martin Cognac, Corona, Budweiser (Budvar), E&J Gallo wines, Carlo Rossi wines, Sutter Home wines, Metaxa Brandy, Sierra Tequila, Teacher�� Whisky, Cinzano, Old Smuggler, Grant�� Whisky and Concha y Toro wines. In addition to its operations in Poland, Russia, and Hungary the Company has Ukraine and distribution agreements for its vodka brands in a number of key export markets including the United Kingdom, Ukraine, the Baltics and the CIS for Green Mark, Zhuravli, Parliament and Zubrowka, the United States, Japan, the United Kingdom, France for Zubrowka and many other Western European countries. In 2011, exports represented 11% of its sales by value.
Poland
In Poland, CEDC is the vodka producers with a brand portfolio that includes Absolwent, Zubrowka, Zubrowka Biala, Bols, Palace and Soplica brands, each of which it p roduces at its Polish distilleries. It produces and sells ! vo! dkas primarily in three vodka sectors: premium, mainstream, and economy. The Company owns two production sites in Poland: one in Oborniki and one in Bialystok. In the Oborniki distillery, it produces the Bols and Soplica vodka brands, among other spirit brands. In Bialystok it produces Absolwent and Zubrowka. Zubrowka is also exported out of Poland to many markets around the world, including the United States, England, Japan and also France. In addition to the Absolwent and Zubrowka brands, in Bialystok it produces the Zubrowka Biala brand. The Company has rights to import and distribute approximately 70 brands of spirits, wine and beer into Poland. It also provides marketing support to the suppliers. During 2011, the Company sold approximately 10.7 million nine-liter cases of vodka, wine and spirits through its Polish business during 2011 including both its own produced vodka brands as well as its exclusive agency import brands. During 2011, the Company sold approximately 1 91 thousand nine-liter cases of Zubrowka outside of Poland. During 2011, the Company�� Polish operations accounted for 26.3% of its revenue.
Russia
CEDC produces Green Mark in Russia and the sub-premium vodkas in Russia, Parliament and Zhuravli. During 2011 the Company introduced new brands to the Russian market Talka, Sotka and Silver Blend. The Company also produces Yamskaya, the economy vodka in Russia, and premixed alcohol drinks, or long drinks. The Company also owns Whitehall, which holds the exclusive rights to the import of such leading premium wine and spirit brands as Concha y Toro, Paul Masson, Robert Mondavi, DeKuyper, Jose Cuervo and Label 5. In addition to these import activities, Whitehall has distribution centers in Moscow, Saint Petersburg, and Rostov as well as a wine and spirits retail network located in Moscow. During 2011, the Company�� Russian operations accounted for 70.2% of its revenue. During 2011,the Company produced a nd sold approximately 16.6 million nine-liter cases of! vodka! t! hrough ! its Russian business in the main vodka segments in Russia: premium, sub-premium, mainstream, economy and cheap. In addition it produced and sold approximately 2.8 million nine-liter cases of long drinks.
Hungary
The Company sells Royal Vodka in Hungary through its Bols Hungary subsidiary. The imported brands to Hungary include Bols Vodka, Zubrowka, Royal Vodka, Campari, Cinzano, Jaegermeister, Bols Liqueurs, Cointreau, Carolans, Galliano, Irish Mist, Jose Cuervo, Calvados Boulard, Remy Martin, Metaxa, St Remy, Grant��, Glenfiddich, Tullamore Dew and Old Smuggler.
Hot Low Price Stocks To Buy For 2014: Odyssey Marine Exploration Inc.(OMEX)
Odyssey Marine Exploration, Inc. provides shipwreck exploration services for use in insurance investigations, and search and recovery operations to governments and deep-ocean mineral exploration companies. The company?s shipwreck projects consist of various activities, including research and development, and search operations; archaeological excavation and recovery operations; and conservation, recording, and documentation. It also sells shipwreck findings, including coins and other mass-produced cargo, cultural collections, and replicas to collectors, museums, and other institutions. Odyssey Marine Exploration, Inc. was founded in 1986 and is headquartered in Tampa, Florida.
Advisors' Opinion:- [By Rich Duprey]
Despite silver falling to around $23 an ounce, and gold going below $1,400, now might be the time to invest in Odyssey Marine Exploration (NASDAQ: OMEX ) , the treasure-hunting shipwreck finder whose own stock is down by a third from its 52-week high.
- [By Jonathan Yates]
That is certainly a better way to profit from gold, SPFR Gold Shares (NYSE: GLD), and silver, iShares Silver Trust (NYSE: SLV). Both the GLD and the SLV have plunged, but sea treasure recovery is very profitable. The find today demonstrates that fact of investing! Odyssey Marine Exploration (NASDAQ: OMEX) had a huge haul off the coast of Ireland earlier this summer, which is more proof of the profit potential for this industry!!.
- [By Sean Williams]
Odyssey Marine Exploration (NASDAQ: OMEX )
I love a good metals play as much as any Fool around here, but Odyssey Marine is certainly not on the buy list. Odyssey Marine is a salvage company that searches for, recovers, and monetizes metals and minerals found on the ocean floor. Make no mistake about it, the job is as cool as it sounds; unfortunately, "cool" doesn't always translate into solid profits. - [By Jonathan Yates]
Investors around the world are becoming more aware of the potential riches to be made by companies in the sea treasure recovery industry such as J.D. Hutt (PINK JABA) and Odyssey Marine Exploration (NASDAQ: OMEX) due to the media attention being paid to the raising of the Concordia. More than $60 billion rests on the ocean floor in gold (NYSE: GLD), silver (NYSE: SLV), and other valuables. As detailed in a previous article on this site, Odyssey Marine Exploration just presented at the 2013 Gateway Conference.
Hot Low Price Stocks To Buy For 2014: Choice Hotels International Inc. (CHH)
Choice Hotels International, Inc., together with its subsidiaries, operates as a hotel franchisor worldwide. It franchises lodging properties under its proprietary brand names, including Comfort Inn, Comfort Suites, Quality, Clarion, Sleep Inn, Econo Lodge, Rodeway Inn, MainStay Suites, Suburban Extended Stay Hotel, Cambria Suites, and Ascend Collection brands. As of March 31, 2011, it operated 6,128 open hotels comprising 492,733 rooms, as well as 606 hotels consisting of 49,908 rooms under construction, awaiting conversion, or approved for development in 49 states, and the District of Columbia in the United States; and approximately 40 countries and other territories. The company was founded in 1981 and is based in Silver Spring, Maryland.
Advisors' Opinion:- [By Seth Jayson]
Calling all cash flows
When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Choice Hotels International (NYSE: CHH ) , whose recent revenue and earnings are plotted below. - [By Sean Williams]
Don't make the wrong Choice
I predict that 2013 will be the return of the "staycation." In the depths of the recession, instead of taking expensive getaways, consumers chose simply to take time off work and stay home or locally. I think we have the perfect confluence of factors that could make life difficult for Choice Hotels International (NYSE: CHH ) , operator of Comfort Inn, Comfort Suites, and a multitude of other mid-price-point hotels. - [By Jeremy Bowman]
What: Shares of Choice Hotels (NYSE: CHH ) were getting picked last by investors today, falling 11% after cutting EPS guidance in its quarterly report.
No comments:
Post a Comment